CellWell record HH-47682

Choline Alfoscerate in the Treatment of Subthreshold Depression in the Elderly: A Pilot Study (CARTESIO)

Filippo Fleishhacker; Annamaria Bonfanti; Nicolò Granata; Claudio Mencacci; Mario Mangrella; Roberto Piazza; Ilaria Coco; Giancarlo Cerveri

2026

In plain language

In an open-label pilot study of 17 adults over 65 with subthreshold depression, choline alfoscerate for eight weeks was associated with significant reductions in depression rating scale scores, though the study had no control group and needs confirmation.

Evidence: Emerging
Design: Primary research (design unspecified)

Read it on PubMed

Cite this record: https://thecellwell.org/studies/HH-47682

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.